Wednesday, September 19, 2012

Why Invest in Theralase?

  • Proven clinical technology (TLC-1000)
  • Commercial therapeutic laser business and brand developed over last 18 years
  • No debt
  • Positive cash flow / double digit growth
  • Competitive technical advantage (Activates 3 cellular pathways: iNOS, ATP, Na+ / K+)
  • Effective in treating pain, inflammation and for tissue regeneration of neural muscular skeletal conditions and wound healing
  • Theralase therapeutic laser system has now been proven clinically effective in the relief of chronic knee pain and for the treatment of osteoarthritis
  • Photo Dynamic Compound (PDC) cancer destruction in animals helps pave the way for human trials
  • Successful pre-clinical trials - total destruction of cancers and bacteria (including MRSA)
  • Large addressable US market ($ billions)
  • Future technology (Patented biofeedback technology and patented PDC cancer destruction)
  • Opportunity for growth (revenue, profit)
  • IP protection (multiple issued patents)
  • Experienced management team (20+ years)
  • Clear vision and execution strategy
  • Listed on the TSX Venture Exchange (TLT:V)

For more information please visit or call 1-866-843-5273 

1 comment:

  1. An Oncological drug protects all different typical signs such as common malignancies. We provide wide range of oncological drugs which are found from efficient and authorized producers. Oncological drugs such as injections, tablets and capsules